| CAMURUS AB |
| Schweden |
| Gesundheit |
| SE0007692850 / A2ABG7 |
| 7CA (Frankfurt) |
| FRA:7CA, ETR:7CA, 7CA:GR |
| - |
| https://www.camurus.com/ |
|
Camurus AB (publ) is a Swedish science-led biopharmaceutical company founded in 1991 and headquartered in Lund, specializing in the research, development, and commercialization of innovative, long-acting medicines for severe and chronic diseases. The..
>Volltext.. |
| 2739 Mio. EUR |
| 2405.67 Mio. EUR |
| 212.35 Mio. EUR |
| 85.22 Mio. EUR |
| 68.95 Mio. EUR |
| 1.16 EUR |
| 9.94 Mio. EUR |
| 349.25 Mio. EUR |
| 81.48 Mio. EUR |
| 10.15 |
| 28.54% |
| 81.95% |
| - |
| - |
| - |
| - |
| CAMURUS |
| 05.04.26 |
|
||||
|
||||
|
||||
|
||||
|